<DOC>
	<DOCNO>NCT01999023</DOCNO>
	<brief_summary>Chronic renal disease tenth lead cause mortality Taiwan . It worth study effect low protein formula retardation fail renal function , decrease plasma homocysteine oxidative stress increase antioxidant capacity patient chronic kidney disease . The purpose study go investigate effect protein formula renal function , homocysteine , oxidative stress antioxidant capacity patient chronic kidney disease . One hundred twenty patient end stage renal disease ( stage 2~4 ) meet inclusion criterion recruit Taichung General Veterans Hospital , Taichung . Participant patient blind randomly assign either placebo ( n = 60 ) low protein formula ( n = 60 ) 12 week . Data demography , anthropometry medical history collect , fast blood sample 24 h urine sample obtain week 0 , 12 24 intervention period . The level hematological , plasma erythrocyte PLP , plasma pyridoxal 4-pyridoxic acid , serum erythrocyte folate , serum vitamin B-12 , homocysteine , lipid peroxidation indicator , glutathione , total antioxidant capacity antioxidant enzymatic measure . Twenty-four hour urine volume record urine creatinine urea nitrogen analyze . Creatinine clearance rate measure . Hopefully , result study could provide picture beneficial effect low protein formula renal function , plasma homocysteine , oxidative stress antioxidant capacity patient chronic kidney disease .</brief_summary>
	<brief_title>Effects Low Protein Formula Renal Function , Oxidative Stress Antioxidant Capacities CKD Patients</brief_title>
	<detailed_description>Chronic renal disease tenth lead cause mortality Taiwan . It worth study effect low protein formula retardation fail renal function , decrease plasma homocysteine oxidative stress increase antioxidant capacity patient chronic kidney disease . The purpose study go investigate effect protein formula renal function , homocysteine , oxidative stress antioxidant capacity patient chronic kidney disease . This protocol design hospital-based blind randomize placebo-controlled intervention trial . One hundred twenty patient end stage renal disease meet inclusion criterion recruit Taichung General Veterans Hospital , Taichung . Participant patient blind randomly assign either placebo ( n = 60 ) low protein formula ( n = 60 ) 12 week . Data demography , anthropometry medical history collect , fast blood sample 24 h urine sample obtain week 0 , 12 24 intervention period . The level hematological ( red blood cell , hemoglobin , albumin , creatinine , urea nitrogen , total cholesterol , triglyceride , high low density lipoprotein ) , plasma erythrocyte PLP , plasma pyridoxal 4-pyridoxic acid , serum erythrocyte folate , serum vitamin B-12 , homocysteine , lipid peroxidation indicator ( serum malondialdehyde oxidize low density lipoprotein ) , glutathione , total antioxidant capacity antioxidant enzymatic activity ( superoxide dismutase , glutathione peroxidase , glutathione S-transferase , glutathione reductase ) measure . Twenty-four hour urine volume record urine creatinine urea nitrogen analyze . Creatinine clearance rate measure . Hopefully , result study could provide picture beneficial effect low protein formula renal function , plasma homocysteine , oxidative stress antioxidant capacity patient chronic kidney disease .</detailed_description>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>1 ) Diagnosed stage 2 ~ 3 chronic kidney disease 1. clinical unstable ( i.e. , systolic blood pressure &lt; 90 mmHg , mean arterial blood pressure &lt; 65 mmHg , fatal arrhythmia requirement vasopressor maintain blood pressure ) unconscious point study . 2. chronic disease ( i.e . liver disease , gastrointestinal disease , alcoholism , cancer ) ; 3 ) pregnant lactation .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>